...
首页> 外文期刊>Molecular medicine reports >Downregulation of microRNA-21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM-1 cells
【24h】

Downregulation of microRNA-21 expression inhibits proliferation, and induces G1 arrest and apoptosis via the PTEN/AKT pathway in SKM-1 cells

机译:MicroRNA-21表达的下调抑制增殖,并通过SKM-1细胞中的PTEN / AKT途径诱导G1停滞和凋亡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and may progress to acute myeloid leukemia (AMU. MicroRNAs (miRNA/miRs) as oncogenes or tumor suppressors regulate a number of biological processes including cell proliferation, cell cycle and apoptosis in different types of cancer cells. Recently, it has been reported that miR-21 as an oncogene is overexpressed and directly targets SMAD-7 in MDS. However, little is known about the mechanism of miR-21 in the progression of MDS. In the present study, the role of miR-21 in the proliferation and apoptosis of SKM-1 cells, an acute myeloid leukemia cell line established in the AML/MDS leukemic phase was investigated. The present results demonstrated that downregulation of miR-21 inhibited proliferation, induced apoptosis and caused G1 phase cell cycle arrest of SKM-1 cells. In addition, the expression levels of apoptosis regulator Bcl-2 (bcl2), cyclinD1 and phosphorylated-protein kinase B (AKT) were significantly decreased in SKM-1 cells transfected with the miR-21 inhibitor, whilst the expression levels of phosphatase and tensin homolog (PTEN), bcl-associated protein X (bax) and cleaved caspase 3 were significantly elevated. Furthermore, knockdown of Akt by small interfering (si)RNA significantly increased the expression of bax, cleaved caspase 3 and reduced the expression of bc12 and cyclinD1 in SKM-1 cells. Taken together, these data indicate that miR-21 targets the PTEN/AKT pathway in the pathogenesis of MDS and could be a potential target for MDS therapy.
机译:肌肌型增生综合征(MDS)的特征是无效的造血症,并且可能对急性髓性白血病(AMU。MicroRNA(miRNA / mir)作为癌肠或肿瘤抑制剂调节许多生物过程,包括细胞增殖,细胞周期和不同类型癌症的细胞凋亡细胞。最近,据报道,作为癌基因的miR-21是过表达的,直接靶向MDS中的Smad-7。然而,关于MDS的进展中miR-21的机制很少。在本研究中,研究了miR-21在SKM-1细胞的增殖和凋亡中的作用,在AML / MDS白血病阶段建立的急性髓性白血病细胞系。本结果表明,MIR-21的下调抑制增殖,诱导细胞凋亡和引起的SKM-1细胞的G1相细胞周期停滞。此外,细胞凋亡调节剂Bcl-2(Bcl2),环壁1和磷酸化 - 蛋白激酶B(akt)的表达水平显着在用miR-21抑制剂转染的SKM-1细胞中减少,而磷酸酶和三素同源物(PTEN),BCL-相关蛋白X(Bax)和切割的Caspase 3的表达水平显着升高。此外,通过小干扰(Si)RNA的Akt敲低显着增加了Bax,切割的胱天蛋白酶3的表达并降低了SKM-1细胞中BC12和Cyclind1的表达。总之,这些数据表明miR-21针对MDS的发病机制中的PTEN / AKT途径,并且可能是MDS疗法的潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号